Pfizer Share Price

Small Cap | Pharmaceuticals and health care | NSE: PFIZER | BSE: 500680

₹4,017.30 image-52.60 (-1.29 %)

Last Updated: 04 Apr 2025 03:53 PM

Technicalsimage BEARISHimage

Overview

Open (₹) 4,069.85

High (₹) 4,069.85

Low (₹) 3,955.00

Prev. Close (₹) 4,069.90

Volume 26,065

VWAP (₹) 3,988.45

ROCE (%) 20.46

Industry P/E 46.49

TTM P/E 29.86

P/B Ratio 5.11

Market Cap (₹) Cr.18,378.24

Dividend Yield (%)0.87

EPS (₹) 120.51

ROE15.33%

Sales Growth (%) -9.55

Profit Growth (%)-11.64

Day Range

4,069.854,069.85

L
H

52 Week Range

3,867.656,452.85

L
H

Historical Returns

Returns (6M)

-28.92 %

Returns (1Y)

-7.17 %

Returns (3Y)

-10.21 %

Returns (5Y)

-5.78 %

Returns (6M)

-28.92 %

Returns (1Y)

-7.17 %

Returns (3Y)

-10.21 %

Returns (5Y)

-5.78 %

SWOT Analysis

  • Bullish MACD crossover (12,6,9) indicates potential upward price movement.
  • Price above the pivot point indicates bullish sentiment.

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bearish
Bullish

RSI 32.30

MFI 73.49

ATR 165.28

Commodity Channel Index -108.91

ROC125 -32.00

ROC21 -10.36

Williams %R -74.87

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current4,123.044,195.324,301.844,016.523,944.243,837.723,765.44
Week Ago4,156.264,217.434,255.364,118.334,057.164,019.233,958.06
Month Ago4,583.514,743.734,828.964,498.284,338.064,252.834,092.61

EMA & SMA
info_icon

4017.30

Current Price

EMA & SMApin

Bullish Moving Averages

0

Bearish Moving Averages

20

5 Day 4100.21


9 Day 4122.24


10 Day 4131.43


12 Day 4122.10


14 Day 4148.16

20 Day 4257.26


26 Day 4329.76


50 Day 4670.76


100 Day 5007.78


200 Day 5119.63

Deals & Announcements

Bulk and Block Deals

No bulk or block deals available.

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
04 May, 2020Anil GuptaAcquisition₹4,200.0025NSE
04 May, 2020Anil GuptaAcquisition₹4,050.00100NSE
04 May, 2020Anil GuptaDisposal₹4,393.33150NSE
04 May, 2020Anil GuptaAcquisition₹4,078.0425NSE
04 May, 2020Anil GuptaAcquisition₹4,116.00125NSE

Corporate Actions

Announcement DateSubjectEx - DateRecord Date
17 May, 2024Rs.35.0000 per share(350%)Final Dividend21 Aug, 202421 Aug, 2024
16 May, 2023Rs.5.0000 per share(50%)Special Dividend11 Aug, 202311 Aug, 2023
15 May, 2023Rs.35.0000 per share(350%)Final Dividend11 Aug, 202311 Aug, 2023

Announcements

DateSourceDetail
01 Apr, 2025NSE IndiaPFIZER LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
01 Apr, 2025NSE IndiaIntimation regarding change in Senior Management Personnel of the Company.
01 Apr, 2025BSE IndiaIntimation regarding change in Senior Management Personnel.
31 Mar, 2025NSE IndiaPfizer Limited has informed the Exchange about Closure of Trading Window
31 Mar, 2025NSE IndiaPfizer Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
29 Mar, 2025NSE IndiaPfizer Limited has informed the Exchange regarding ''Update on transfer and assignment of Pfizer s unexpired leasehold rights in the landsituated at Plot No. 16, Trans Thane Creek Industrial Area, Turbhe, Thane and sale ofstructures and buildings constructed thereon, to Zoetis Pharmaceutical ResearchPrivate Limited.''.
29 Mar, 2025BSE IndiaUpdate on Transfer and Assignment of MIDC Land and Buildings constructed thereon.
21 Feb, 2025NSE IndiaPursuant to the Regulation 30 of the Listing Regulations, we hereby inform that, the Board ofDirectors of the Company at their Meeting held today, that commenced on February 20, 2025at 11.00 a.m. and concluded on February 21, 2025 at 1.45 p.m have approved a proposal today,to enter into a Marketing and Supply Agreement with Mylan Pharmaceuticals Private Limited( Mylan ) for Marketing and Sale of two brands of the Company, viz., Ativan and Pacitane.
21 Feb, 2025BSE IndiaPursuant to the Regulation 30 of the Listing Regulations, we hereby inform that, the Board of Directors of the Company at their Meeting held today, that commenced on February 20, 2025 at 11.00 a.m. and concluded on February 21, 2025 at 1.45 p.m have approved a proposal today, to enter into a Marketing and Supply Agreement with Mylan Pharmaceuticals Private Limited for Marketing and Sale of two brands of the Company, viz., Ativan and Pacitane.
14 Feb, 2025NSE IndiaPFIZER LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results--28 Jan, 202531 Jan, 2025
Quarterly Results--22 Oct, 202428 Oct, 2024
Quarterly Results--23 Jul, 202429 Jul, 2024
Audited Results & Final Dividend--07 May, 202417 May, 2024
Quarterly Results--01 Feb, 202409 Feb, 2024
Quarterly Results--19 Oct, 202328 Oct, 2023
Quarterly Results--07 Aug, 202311 Aug, 2023
Audited Results & Final Dividend--08 May, 202315 May, 2023
Quarterly Results--03 Feb, 202309 Feb, 2023
Quarterly Results--04 Nov, 202211 Nov, 2022

Share Holding Pattern

Loading...

Loading...

Owner NameDec, 2024Dec, 2023Dec, 2022Dec, 2021Dec, 2020
Promoter Group63.92%63.92%63.92%63.92%63.92%
Foreign Institutions +2.74%3.03%2.77%2.13%1.87%
Domestic Institutions +16.8%15.15%14.93%15.02%14.31%
Government0%0%0%0%0%
Public16.54%17.9%18.38%18.93%19.9%
Others0%0%0%0%0%

About Pfizer

Pfizer is a Public Limited Listed company incorporated on 21/11/1950 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24231MH1950PLC008311 and registration number is 008311. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 2193.17 Cr. and Equity Capital is Rs. 45.75 Cr. for the Year ended 31/03/2024. Read More

Parent Organisation

MNC Associate

Founded

1950

Managing Director

Ms. Meenakshi Nevatia

NSE Symbol

PFIZER

Pfizer Management

NameDesignation
Mr. Pradip ShahChairman & Ind.Director
Ms. Meenakshi NevatiaManaging Director
Mr. P RenganExecutive Director - Operations
Mr. Amit AgarwalExecutive Director & CFO
Mr. Sunil LalbhaiIndependent Director
Mr. Uday KhannaIndependent Director
Ms. Meena GaneshIndependent Director
Mr. Lakshmanan KrishnakumarIndependent Director
Ms. Sonia SinghIndependent Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Sun Pharmaceutical Industries₹4,24,682.29₹1,709.35 image
₹1,770.00(-3.43%)
₹1,376.750 - ₹1,960.200
Divi's Laboratories₹1,52,989.54₹5,482.85 image
₹5,763.00(-4.86%)
₹3,556.300 - ₹6,448.750
Cipla₹1,20,795.29₹1,415.25 image
₹1,495.70(-5.38%)
₹1,317.600 - ₹1,702.000
Torrent Pharmaceuticals₹1,09,916.93₹3,286.50 image
₹3,247.70(1.19%)
₹2,508.650 - ₹3,589.950
Mankind Pharma₹1,00,161.69₹2,451.20 image
₹2,427.70(0.97%)
₹1,910.100 - ₹3,050.000

FAQs on Pfizer

What is the share price of Pfizer?

The share price of Pfizer on 04 Apr, 2025 is ₹ 4,017.30.

What is 52W high and 52W low share price of Pfizer?

The highest and lowest 52W share prices of Pfizer are ₹ 6452.850 and ₹ 3867.650

What is the market cap of Pfizer?

The market capitalization of Pfizer as of 04 Apr, 2025 is ₹ 18,378.24 Crores

What is the P/E ratio of Pfizer?

The current P/E ratio of Pfizer as of 04 Apr, 2025 is 46.49

What is the PB ratio of Pfizer?

The PB ratio of Pfizer as of 04 Apr, 2025 is 5.11

Top Gainers

₹109.04image

₹90.87 (0.20%)

₹75.34image

₹62.79 (0.20%)

₹143.15image

₹119.30 (0.20%)

₹3.81image

₹3.18 (0.20%)

Top Losers

₹3,206.90image

₹3,774.25 (-0.15%)

₹28.50image

₹32.80 (-0.13%)

₹950.60image

₹1,188.25 (-0.20%)

₹753.20image

₹889.55 (-0.15%)

Market Indices

Sensex

₹76,295.36image

₹76,617.44 (0.00%)

Source : Dion Global Solutions Limited